Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,081.65
(
-2.73%
)
News Focus
News Focus
Post# of 257391
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

walldiver

Send PM Follow Ignore
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

walldiver

Re: DewDiligence post# 32060

Sunday, 07/30/2006 5:03:36 PM

Sunday, July 30, 2006 5:03:36 PM

Post# of 257391
GTOP vs OSIP pivotal Phase III

Dew, wasn't the Tarceva monotherapy trial in 2nd and 3rd-line NSCLC the only pivotal trial that OSIP conducted for that indication? In reading the company press releases, it was strongly implied that the p value threshold for that trial was 0.05.

Same thing with the Tarceva + Gemzar Phase III in pancreatic.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today